ABPI names Haseeb Ahmad as President
The ABPI names Haseeb Ahmad as President. Haseeb Ahmad, Managing Director, UK, Ireland & Nordics Novartis Pharmaceuticals and Country President Novartis UK has been confirmed...
Novartis presents new migraine data for Aimovig®▼ (erenumab)
Novartis presents new migraine data for Aimovig®▼ (erenumab) demonstrating sustained efficacy to 52 weeks. Novartis has announced that new data from two follow-up studies of...
AMAL Therapeutics enters clinical collaboration with Boehringer Ingelheim
AMAL Therapeutics (AMAL), a Swiss biotech developing novel, peptide-based therapeutic cancer vaccines, has entered into a collaborative agreement with Boehringer Ingelheim. AMAL will conduct an...
ABPI responds to Accelerated Access Collaborative announcement
The UK Government is to announce at the ABPI Conference that the most promising treatments will be fast-tracked by the new and boosted Accelerated...
Sandoz enters agreement for proposed trastuzumab biosimilar
Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors. Sandoz, a Novartis division, has announced that...
ViiV Healthcare submit New Drug Application for injectable HIV treatment
ViiV Healthcare has submitted a New Drug Application to the FDA for the monthly injectable HIV treatment, a two-drug regimen of cabotegravir and rilpivirine. ViiV Healthcare,...
FDA approval of Praluent ® to prevent heart attack, stroke & unstable angina
The FDA approval of Praluent ® (alirocumab) to reduce the risk of heart attack, stroke, and unstable angina requiring hospitalisation. The U.S. Food and Drug Administration...
Space technology to fight bowel cancer and exposure to air pollution
The UK Space Agency and Science Minister have announced the use of space technology to fight bowel cancer and exposure to air pollution. The...
Medicines Discovery Catapult partners with UK contract research organisations
Medicines Discovery Catapult partners with UK contract research organisations (CROs) leveraging the UK’s renowned contract research sector to boost industrial growth. Medicines Discovery Catapult has...
Collaboration to develop potential new pain medicines
LifeArc® has signed a deal with The University of Kent to develop potential new pain medicines. They will collaborate on an ion channel drug discovery...
Latest articles
Changes to GSK sales representative incentive programme
GSK has announced changes to its sales representative incentive programme for representatives in certain countries. These changes reflect the growing shift in GSK’s portfolio...
Peer-to-peer mental health support app goes live
The UK's first free peer-to-peer mental health support app, 'Unmasked', has gone live after a period of extensive testing. The brainchild of three Yorkshiremen, Logan...
Drug firms accused of illegal market sharing over anti-nausea tablets
The Competitions and Markets Authority (CMA) has accused four pharmaceutical companies of illegal market sharing over anti-nausea tablets. The CMA has provisionally found that the pharmaceutical...
Popular articles
Peer-to-peer mental health support app goes live
The UK's first free peer-to-peer mental health support app, 'Unmasked', has gone live after a period of extensive testing. The brainchild of three Yorkshiremen, Logan...
NICE issues final guidance for Tegsedi ®▼
Akcea Therapeutics UK Ltd, an affiliate of Akcea Therapeutics, Inc announced that the National Institute for Health and Care Excellence (NICE) has published its...
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Changes to GSK sales representative incentive programme
GSK has announced changes to its sales representative incentive programme for representatives in certain countries. These changes reflect the growing shift in GSK’s portfolio...
Wasdell Group expands portfolio with Honeywood acquisition
The Wasdell Group (Wasdell), a leading outsourcing partner for companies in the pharmaceutical industry, has announced its acquisition of Honeywood Limited, a specialist manufacturer...